{
  "ticker": "VRTX",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T12:45:33.214155",
  "count": 30,
  "transactions": [
    {
      "id": 8262,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 22124,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Biller Jonathan",
      "reporting_owner_cik": "0001744749",
      "reporting_owner_position": "EVP and Chief Legal Officer",
      "transaction_date": "2022-09-19",
      "transaction_shares": "5294",
      "transaction_price": "0.00",
      "transaction_type": "A",
      "shares_after_transaction": "5294"
    },
    {
      "id": 8236,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 8260,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 8268,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 22091,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-15",
      "transaction_shares": "6571",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "67451"
    },
    {
      "id": 22120,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-15",
      "transaction_shares": "206",
      "transaction_price": "300.26",
      "transaction_type": "S",
      "shares_after_transaction": "13146"
    },
    {
      "id": 22132,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Kewalramani Reshma",
      "reporting_owner_cik": "0001735944",
      "reporting_owner_position": "CEO & President",
      "transaction_date": "2022-08-15",
      "transaction_shares": "11689",
      "transaction_price": "305.06",
      "transaction_type": "S",
      "shares_after_transaction": "99598"
    },
    {
      "id": 8229,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 8252,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 22084,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-10",
      "transaction_shares": "36",
      "transaction_price": "300.32",
      "transaction_type": "S",
      "shares_after_transaction": "13352"
    },
    {
      "id": 22109,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-10",
      "transaction_shares": "64",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "61060"
    },
    {
      "id": 8245,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 8251,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 8266,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 22102,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Tatsis Ourania",
      "reporting_owner_cik": "0001789815",
      "reporting_owner_position": "EVP, Chief Reg. & Quality Off.",
      "transaction_date": "2022-08-09",
      "transaction_shares": "292",
      "transaction_price": "297.54",
      "transaction_type": "S",
      "shares_after_transaction": "47198"
    },
    {
      "id": 22108,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Liu Joy",
      "reporting_owner_cik": "0001847529",
      "reporting_owner_position": "SVP, General Counsel",
      "transaction_date": "2022-08-09",
      "transaction_shares": "946",
      "transaction_price": "300.00",
      "transaction_type": "S",
      "shares_after_transaction": "13388"
    },
    {
      "id": 22129,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Arbuckle Stuart A",
      "reporting_owner_cik": "0001557290",
      "reporting_owner_position": "EVP, COO",
      "transaction_date": "2022-08-09",
      "transaction_shares": "1926",
      "transaction_price": "155.57",
      "transaction_type": "M",
      "shares_after_transaction": "66686"
    },
    {
      "id": 8242,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 8261,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 22098,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-08-08",
      "transaction_shares": "1304",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "37381"
    },
    {
      "id": 22122,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-08",
      "transaction_shares": "45",
      "transaction_price": "290.18",
      "transaction_type": "S",
      "shares_after_transaction": "5237"
    },
    {
      "id": 8231,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 22086,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Sanna Bastiano",
      "reporting_owner_cik": "0001829069",
      "reporting_owner_position": "EVP, Cell & Genetic Therapies",
      "transaction_date": "2022-08-01",
      "transaction_shares": "766",
      "transaction_price": "276.62",
      "transaction_type": "F",
      "shares_after_transaction": "40983"
    },
    {
      "id": 8232,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 22087,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "Bhatia Sangeeta N.",
      "reporting_owner_cik": "0001643921",
      "reporting_owner_position": null,
      "transaction_date": "2022-07-29",
      "transaction_shares": "99",
      "transaction_price": "276.65",
      "transaction_type": "S",
      "shares_after_transaction": "5804"
    },
    {
      "id": 8267,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 22130,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "LEIDEN JEFFREY M",
      "reporting_owner_cik": "0001242825",
      "reporting_owner_position": "Executive Chairman",
      "transaction_date": "2022-07-25",
      "transaction_shares": "60342",
      "transaction_price": "91.05",
      "transaction_type": "M",
      "shares_after_transaction": "134502"
    },
    {
      "id": 8253,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    },
    {
      "id": 22110,
      "issuer_name": "VERTEX PHARMACEUTICALS INC / MA",
      "reporting_owner": "ALTSHULER DAVID",
      "reporting_owner_cik": "0001550395",
      "reporting_owner_position": "EVP, Global Research and CSO",
      "transaction_date": "2022-07-19",
      "transaction_shares": "10427",
      "transaction_price": "187.53",
      "transaction_type": "M",
      "shares_after_transaction": "46604"
    }
  ]
}